OpenAI CEO Sam Altman is reportedly in talks with former President Trump about giving the US government a 5% stake in the company, aiming to share AI-generated wealth with American households. This plan seeks to compensate creators and provide a safety net against AI's impact on the job market.
Researchers from Technion and Tel Aviv University have developed BetaDescribe, an AI system that translates protein sequences into natural-language descriptions. This breakthrough promises to accelerate drug development and material design by revealing the functions of unknown proteins.
Despite widespread public distrust in AI, some of America's wealthiest families are paying tens of thousands of dollars to enroll their children in AI-driven schools, turning them into beta testers for unproven educational technology. This trend raises concerns about efficacy, critical thinking development, and the deliberate exclusion of crucial social topics from the curriculum.
Anthropic, known for its AI models, is not only offering AI tools for drug discovery but also plans to develop its own drugs, focusing on "neglected" diseases. This bold move positions it uniquely as both a software vendor and a potential competitor, though the path to AI-designed drugs reaching patients remains long and complex.
Negotiations between Google DeepMind and its London-based employees over unionization have stumbled, with union representatives expressing frustration over the absence of senior leadership and allegations of union-busting tactics. The company denies stalling, while employees cite ethical concerns over AI militarization as a key driver for their push.
Scientists are combining generative AI and physics-based simulations to design new antibiotics, a crucial step in combating antibiotic-resistant infections projected to cause over 8 million deaths annually by 2050. This innovative approach promises to accelerate drug discovery, reducing costs and increasing success rates.
Anthropic has launched Claude Science, a flagship AI product designed to revolutionize scientific research, particularly in computational biology and drug development. This move signals Anthropic's serious commitment to leveraging AI for humanity's long-term well-being, directly challenging established leaders in the field.
OpenAI CEO Sam Altman has proposed donating 5% of the company's equity to a U.S. sovereign wealth fund, aiming to secure good relations with the administration and address political blowback. This move is part of a broader discussion about democratizing the economic benefits of AI.
SpaceX has reportedly showcased a "handset-like" AI device prototype to investors, hinting at a potential entry into the AI hardware market, despite Elon Musk's swift denial. The device is described as sleeker than an iPhone and aims to integrate proprietary AI technology.
OpenAI is reportedly considering offering the US government a 5% ownership stake, a move aimed at easing tensions with the Trump administration and potentially averting stringent regulations. This strategic proposal, valued at approximately $42.6 billion, seeks to share the benefits of AI with the public.
Mainstream large language models often fall into a "groupthink" rut, producing predictable and uncreative responses. Australian startup Springboards introduces Flint, an LLM designed to break this pattern by embracing diverse and novel outputs, challenging AI's inherent biases.
The U.S. has lifted export restrictions on Anthropic's advanced AI models, Mythos and Fable, restoring public access after weeks of negotiations. This decision comes as Anthropic commits to enhanced security measures and amid increasing global competition from Asian AI firms.
New research published in Nature reveals that multi-agent AI systems can now autonomously devise scientific hypotheses and formulate methods to test them, significantly accelerating the pace of discovery. This marks a pivotal shift in scientific methodology, augmenting human capabilities in unprecedented ways.
New research suggests that framing AI agents as "coworkers" or "employees" significantly reduces human accountability and performance, leading to more errors and misplaced blame. This approach fundamentally misunderstands AI's role and capabilities.
A new report challenges the grim narrative of AI-driven job losses, suggesting that companies heavily investing in AI are actually growing their headcount faster, even in entry-level roles. However, the data primarily reflects tech-forward firms, complicating the broader implications for the job market.
South Korean tech giants, including Samsung and SK Hynix, are investing over $900 billion in semiconductors and AI infrastructure to combat the global memory chip shortage and solidify the nation's AI leadership. This massive national plan includes building new fabs and AI data centers across the country.
Meta contractors posed as minors to test rival AI chatbots on highly sensitive topics like suicide, sex, and drug use, sparking ethical concerns. The project, known as Cannes, involved creating dummy under-18 accounts and sending thousands of provocative prompts to ChatGPT, Gemini, and Character.AI.
Researchers have developed a novel method to guide the AI-based AlphaFold with experimental data, overcoming its limitation of predicting only a single dominant protein conformation. This breakthrough promises more accurate predictive models for protein structures.
OpenAI is limiting the release of its newest AI models, the GPT-5.6 lineup, to a "small group of trusted partners" at the request of the U.S. government. The company expressed its dissatisfaction with the arrangement, stating that such restrictions should not become the long-term default.
OpenAI is bolstering its team with Google DeepMind AI legend Noam Shazeer and former Trump White House AI policy official Dean Ball as it prepares for its public debut. These strategic hires aim to strengthen both its technical leadership and its ability to shape frontier AI policy.
A new study reveals that physicians' ability to detect precancerous growths declined after they grew accustomed to an AI tool, raising concerns about skill atrophy due to over-reliance on artificial intelligence.
A new study from Google DeepMind introduces AMIE, an AI system that demonstrated superior capabilities in disease management reasoning, outperforming primary care physicians in virtual clinical trials, particularly in treatment precision and medication reasoning.
Odyssey, an AI startup pioneering 'world models,' has raised $310 million in Series B funding, achieving a $1.45 billion valuation with backing from Amazon, AMD Ventures, and GV. The company, founded by self-driving vehicle veterans, specializes in simulating the physical world with accurate physics for applications ranging from gaming to robotics.
The Trump administration is intensifying pressure on AI developer Anthropic to prevent 'jailbreaks' in its advanced models, particularly Claude Fable 5, amidst broader political disputes over intelligence appointments and high-profile tech lobbying events.
